Emeritus Professor Shane Darke, a leading expert on substance use health effects, recently presented compelling findings during an NDARC webinar examining the clinical characteristics of heroin overdose deaths amongst older adults in Australia. The research reveals a concerning new demographic trend that challenges long-held assumptions about substance use patterns and age.

The study utilised Australia’s National Coronial Information System to examine heroin-related deaths among people aged 65 and above between 2000 and 2025, uncovering critical insights about this emerging population and the circumstances surrounding these fatal outcomes.

The Emergence of Heroin Overdose Deaths in Elderly Populations

For decades, the prevailing view was that people would “mature out” of heroin use by their thirties. However, recent data paints a starkly different picture. In the 1990s, the average age of heroin overdose deaths was 31, with the oldest cases in their fifties. By the early 2020s, this average had risen to 42, with cases now extending into the eighties.

The study identified 59 heroin overdose deaths among people aged 65 and above, with a remarkable timeline of emergence. No cases occurred in the first decade of the 2000s, only two cases between 2011-2015, but 36 cases from 2016-2020. This represents a new phenomenon requiring urgent attention from public health authorities.

Most significantly, 22 of these cases involved people in their seventies or above, demonstrating that heroin use can persist well into advanced age. These were not individuals who began using substances late in life, but rather people with longstanding use histories spanning decades.

Understanding Fatal Opioid Overdoses and Their Mechanisms

Heroin overdose deaths fundamentally involve respiratory depression. As Professor Darke explains, heroin is a powerful central nervous system depressant that suppresses breathing responses. Even among people with high tolerance who have used for years, respiratory rates can drop to just four breaths per minute.

The typical progression involves a cascade from lower respiration rates to loss of consciousness, coma, and ultimately death. This differs significantly from stimulant drugs like methamphetamine, which primarily affect cardiovascular function.

Research using six-monoacetylmorphine (6-MAM) detection provides crucial insights into survival times. When this heroin metabolite is present in blood at death, it indicates the person died within approximately 20-30 minutes of use. Remarkably, two-thirds of the elderly cases showed evidence of these shorter survival times, compared to only one-third of those under 30.

Health Complications in Older Heroin Users

The study revealed significant health complications among older users. Through autopsy findings, researchers documented extensive disease burden, including severe coronary artery disease in over half of examined cases, cardiomegaly in one-third, and liver fibrosis approaching cirrhosis in 26% of cases.

Chronic obstructive pulmonary disease (COPD) appeared particularly relevant, as these respiratory conditions compound the breathing difficulties caused by heroin use. The combination of a respiratory depressant drug with compromised lung function creates heightened risk scenarios.

Disease played a contributory role in 40% of overdose deaths among those over 50, compared to just 3% in those under 30. This dramatic difference suggests that underlying health conditions significantly influence overdose risk in elderly populations.

Treatment Access and Intervention Challenges

Despite the documented health risks and long-standing substance use problems, only seven of the 59 individuals were enrolled in drug treatment programmes at the time of death. This represents a critical gap, as treatment engagement can reduce overdose risk by approximately 30-fold.

The research identified several barriers to intervention. Most deaths occurred in private settings, often with the person alone or in a separate room from others present. While 29 cases had someone in the immediate vicinity, only 12 received medical intervention prior to death.

Naloxone detection occurred in fewer than 3% of cases, highlighting the importance of ensuring this life-saving medication is readily available. The introduction of nasal spray formulations removes the need for injection expertise, making administration possible for a broader range of bystanders.

Addressing Heroin Overdose Deaths Through Targeted Approaches

The findings suggest several important intervention strategies. Treatment programmes must recognise that age should not be a barrier to accessing opioid substitution therapy or residential rehabilitation. Some cases may require innovative approaches, such as considering methadone dosing in nursing home settings.

Rapid response systems become crucial given the shortened survival times observed in older users. Professor Darke discussed the potential for wearable technology that could alert caregivers when someone collapses or stops moving, providing intervention opportunities when others aren’t immediately present.

The role of polydrug use cannot be ignored, as 87% of cases involved other substances, particularly central nervous system depressants like benzodiazepines. These combinations significantly increase overdose risk by compounding respiratory depression.

Implications for Understanding Fatal Opioid Overdoses

This research challenges assumptions about substance use trajectories and highlights the need for age-inclusive prevention and treatment approaches. The emergence of heroin overdose deaths among elderly populations represents a new public health challenge requiring specialised responses.

The findings demonstrate that tolerance to heroin’s euphoric effects develops faster than tolerance to its respiratory depression effects. Furthermore, as people age, their ability to metabolise drugs decreases, potentially making the same doses more dangerous than in younger years.

Professor Joe Dodd, the forensic pathologist who joined the discussion, emphasised that elderly people have different metabolism patterns, with opioids having longer half-lives and decreased tolerance compared to younger individuals. This metabolic reality compounds the risks associated with continued use into advanced age.

Future Directions and Research Needs

The study reveals significant gaps in understanding this population. Limited autopsy rates in recent years may mean the actual numbers of heroin overdose deaths among elderly people are being underestimated. Many deaths might receive medical certificates without consideration of possible heroin involvement, particularly when they occur in healthcare settings.

The research also highlights the need for routine toxicological testing for substances like nicotine, which could provide important context about health behaviours and risk factors. Currently, most jurisdictions don’t include nicotine testing, despite its relevance to understanding the complete health picture.

Moving forward, researchers suggest the need for qualitative studies with living older heroin users to better understand their experiences, health behaviours, and intervention needs. Such research could inform more effective prevention and treatment strategies tailored to this emerging demographic.

The study represents the first comprehensive examination of heroin overdose deaths among people aged 65 and above, utilising Australia’s unique national coronial database. This systematic approach provides insights impossible to achieve in other countries lacking similar data infrastructure.

Understanding these patterns becomes crucial as the population of long-term heroin users continues to age, requiring health systems to adapt their approaches to address the complex needs of elderly people with substance use disorders and multiple health complications.

Source: UNSW